These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
923 related items for PubMed ID: 16052595
1. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Holman AJ, Myers RR. Arthritis Rheum; 2005 Aug; 52(8):2495-505. PubMed ID: 16052595 [Abstract] [Full Text] [Related]
3. Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U. Arthritis Rheum; 2010 Jan; 62(1):291-300. PubMed ID: 20039417 [Abstract] [Full Text] [Related]
4. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R. Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [Abstract] [Full Text] [Related]
6. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens. Wymer JP, Simpson J, Sen D, Bongardt S, Lacosamide SP742 Study Group. Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870 [Abstract] [Full Text] [Related]
7. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Russell IJ, Perkins AT, Michalek JE, Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896 [Abstract] [Full Text] [Related]
8. Safety and efficacy of esreboxetine in patients with fibromyalgia: a fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial. Arnold LM, Hirsch I, Sanders P, Ellis A, Hughes B. Arthritis Rheum; 2012 Jul; 64(7):2387-97. PubMed ID: 22275142 [Abstract] [Full Text] [Related]
9. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Lee EY, Lee EB, Park BJ, Lee CK, Yoo B, Lim MK, Shim SC, Sheen DH, Seo YI, Kim HA, Baek HJ, Song YW. Clin Ther; 2006 Dec; 28(12):2052-60. PubMed ID: 17296461 [Abstract] [Full Text] [Related]
10. History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release. Pae CU, Masand PS, Marks DM, Krulewicz S, Han C, Peindl K, Mannelli P, Patkar AA. World J Biol Psychiatry; 2009 Dec; 10(4 Pt 2):435-41. PubMed ID: 19382010 [Abstract] [Full Text] [Related]
11. Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial. Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S. Rheumatol Int; 2002 Sep; 22(5):188-93. PubMed ID: 12215864 [Abstract] [Full Text] [Related]
14. An open-label study of quetiapine in the treatment of fibromyalgia. Hidalgo J, Rico-Villademoros F, Calandre EP. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):71-7. PubMed ID: 16889882 [Abstract] [Full Text] [Related]
18. No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study. Kendall SA, Schaadt ML, Graff LB, Wittrup I, Malmskov H, Krogsgaard K, Bartels EM, Bliddal H, Danneskiold-Samsøe B. J Rheumatol; 2004 Apr 30; 31(4):783-4. PubMed ID: 15088307 [Abstract] [Full Text] [Related]
19. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study. Inoue Y, Hirata K, Kuroda K, Fujita M, Shimizu T, Emura N, Uchimura N, Kagimura T, Sha K, Nozawa T. Sleep Med; 2010 Jan 30; 11(1):11-6. PubMed ID: 19962941 [Abstract] [Full Text] [Related]